NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New italian test aims to catch deadly swallowing problems sooner
Diagnosis CompletedThis study aimed to create an Italian version of a test that helps doctors assess swallowing problems (dysphagia) in people with neurodegenerative diseases like Parkinson's and ALS. Swallowing problems are common and can lead to serious complications like pneumonia. The researche…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
Intense workouts tested to fight Parkinson's decline
Symptom relief CompletedThis study tested whether a specific type of high-intensity exercise could help people with Parkinson's disease. Fifteen participants with early-stage Parkinson's who could walk independently tried a High-Intensity Functional Training (HIFT) program. Researchers compared HIFT, wh…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Valencia • Aim: Symptom relief
Last updated Apr 01, 2026 21:41 UTC
-
Can watching videos help people with Parkinson's walk better?
Symptom relief CompletedThis study tested if adding 'action observation therapy'—watching videos of people performing movements—to standard physical therapy helps people with Parkinson's disease walk more easily. It involved 42 participants to see if this combined approach could reduce episodes of 'free…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
First human tests begin for potential brain disease drug
Knowledge-focused CompletedThis was an early-stage study to check the safety and see how the body processes a new drug called GV1001, which is being developed for brain diseases. It involved 59 healthy volunteers who received either the drug or a placebo as a single shot or multiple shots over several week…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1 • Sponsor: GemVax & Kael • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC